Sio Gene Therapies Inc SIOX:NASDAQ

RT Quote | Last NYSE Arca, VOL From CTA | USD
after hours iconAfter Hours: Last | 4:35 PM EST
2.60quote price arrow up+0.04 (+1.56%)
Volume
3,994
Close
2.56quote price arrow down-0.22 (-7.91%)
Volume
2,932,025
52 week range
1.41 - 5.74

...

Loading . . .

KEY STATS

  • Open2.76
  • Day High2.79
  • Day Low2.40
  • Prev Close2.78
  • 52 Week High5.74
  • 52 Week High Date10/05/20
  • 52 Week Low1.41
  • 52 Week Low Date03/18/20
  • Market Cap150.40M
  • Shares Out58.75M
  • 10 Day Average Volume2.31M
  • Dividend-
  • Dividend Yield-
  • Beta1.72
  • 1 Year % Change-14.95

RATIOS/PROFITABILITY

  • EPS (TTM)-1.15
  • P/E (TTM)-2.22
  • Fwd P/E (NTM)-
  • EBITDA (MRQ)-45.067M
  • ROE (MRQ)-97.24%
  • Revenue (MRQ)0.00
  • Gross Margin (MRQ)-
  • Net Margin (MRQ)-
  • Debt To Equity (MRQ)0.00%

EVENTS

  • Earnings Date-
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest Sio Gene Therapies Inc News

There is no recent news for this security.

Latest SIOX News From Our Partners

There is no recent news for this security.

QUOTE FINDER

Profile

MORE
Sio Gene Therapies Inc., together with its wholly owned subsidiaries, is a clinical-stage company focused on developing gene therapies for neurodegenerative diseases. The Company is developing a pipeline of product candidates for the treatment of these debilitating diseases, including Parkinson's disease, GM1 gangliosidosis and GM2 gangliosidosis (including Tay-Sachs disease and Sandhoff disease). The Company’s subsidiaries include Axovant Holdings Ltd, Axovant Sciences Inc...
Address
130 West 42Nd Street, 26Th Floor
New York, NY
10036
United States